Get the content you want anytime you want.

Latest News From Contagion Live

Latest News

Examining Stress, Depression, and Anxiety Levels in Pregnant Women in the Time of Zika
Both Zika-infected and uninfected pregnant women showed levels of high stress in a recent study conducted in Puerto Rico.
Zika Virus and Chikungunya Co-Infection May Result in Prolonged Infection
At the First International Conference on Zika Virus, Marta G. Cavalcanti, MD, PhD, discussed her team’s recent research regarding viral RNA shedding in symptomatic and asymptomatic Zika patients who are either mono-infected with Zika or Chikungunya, or co-infected with both.
Zika Around the World: A History
At the First International Zika Conference, keynote speaker Annelies Wilder-Smith, MD, PhD, DTM&H, MIH, FAMS, FACTM, discussed how Zika has evolved on a global scale.
NSAIDs Given for Flu Could Increase Odds of Heart Attack
The results of a new study suggest a 3-7% increase in the likelihood of having a heart attack in some patients with acute respiratory infections also takes nonsteroidal anti-inflammatory drugs (NSAIDs).
Rapid Test for Antibiotic Sensitivity in Blood Infections Approved by FDA
The US Food and Drug Administration just announced that it is allowing the marketing of a new test kit for bloodstream infections.
Could Oritavancin Be a Safe Alternative to Vancomycin for ABSSSIs?
A single dose of the antibiotic oritavancin could save patients and health services time and money when treating acute bacterial skin and skin structure infections (ABSSSIs).
Zika Virus Remains in Bodily Fluids Longer Than Other Flaviviruses
In the first study to examine multiple body fluids for the presence of Zika virus in an ongoing fashion, researchers discover Zika virus remains in bodily fluids longer than other flaviviruses.
Both Viral and Human Genetics Influence HIV Disease Progression
New research suggests that human and viral genetics account for one third of the differences in disease progression rates in HIV-positive individuals.
A recent study from US researchers suggests that liver disease severity and treatment costs for people with hepatitis C (HCV) vary depending on a patient's genotype.